Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil ED50 for Rapid Sequence Intubation
NCT03065309Phase 3Completed
- Sponsor
- Hospital Universitário de Brasília
- Start
- Feb 2017
- Primary completion
- Feb 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, single-arm trial of remifentanil, sponsored by Hospital Universitário de Brasília. Primary endpoint: Hemodynamic stability during rapid sequence intubation at 5 months. Started Feb 2017; status: completed.
02
Drugs
remifentanil
Beyond the preview
Go deeper on NCT03065309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03065309.